Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0000950170-24-101926

Director sold 4,555 shares at $2.93 ($13,353)

  • Director acquired 4,555 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Meeker David P · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-27 Exercise or conversion : show line 1 in the form +4,555 $1.43 $6,514 357,044 D
2024-08-27 Sale : show line 2 in the form −4,555 $2.93 $13,353 352,489 D
Open-market sales · 4,555 sh · avg $2.93 · $13,353

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-27 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −4,555 0 D
Loading xslF345X05/ownership.xml…